US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 167 actively recruiting studies with Wisconsin sites out of 167 registered in total. The busiest research areas in Wisconsin are Breast Cancer, Prostate Cancer, Colorectal Cancer. Leading sponsors running trials in the state include University of Wisconsin, Madison, Medical College of Wisconsin, National Cancer Institute (NCI). By stage, Wisconsin trials break down as Phase 1 (34), Phase 2 (47), Phase 3 (43), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
167
Recruiting Now
167
← Back to US Map
Top Conditions in Wisconsin
Breast Cancer (5)Prostate Cancer (4)Colorectal Cancer (3)Solid Tumor (3)Acute Myeloid Leukemia (3)Anxiety (3)Heart Failure (3)Mantle Cell Lymphoma (MCL) (3)Healthy (2)Metastatic Castration-resistant Prostate Cancer (2)Pancreatic Ductal Adenocarcinoma (2)Relapsing Remitting Multiple Sclerosis (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 167 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 167. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT05866471 Phase 1
Recruiting
The ENHANCE Study: taVNS and Psilocybin
Condition
Healthy
Enrollment
115 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
View Trial →
NCT05919264 Phase 1, Phase 2
Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Condition
Cancer
Enrollment
619 pts
Location
United States, Australia
Sponsor
Parabilis Medicines, Inc.
View Trial →
NCT05254171 Phase 2, Phase 3
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Ca...
Condition
Pancreatic Cancer Metastatic
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Panbela Therapeutics, Inc.
View Trial →
NCT04047628 Phase 3
Recruiting
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for ...
Condition
Relapsing Multiple Sclerosis
Enrollment
156 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
View Trial →
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
View Trial →
NCT06095505 Phase 2
Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Condition
Small Cell Lung Cancer
Enrollment
120 pts
Location
United States
Sponsor
Puma Biotechnology, Inc.
View Trial →
NCT05489705 N/A
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treat...
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
1,700 pts
Location
United States, Austria, Czechia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
View Trial →
NCT07464353 N/A
Recruiting
xDot Access Management System Early Feasibility Study
Condition
Vascular Closure Devices
Enrollment
30 pts
Location
United States
Sponsor
xDot Medical, Inc
View Trial →
NCT06742996 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib ...
Condition
Mantle Cell Lymphoma
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
BeOne Medicines
View Trial →
NCT03945162 Phase 2
Recruiting
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Mus...
Condition
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Enrollment
90 pts
Location
United States, Canada
Sponsor
Theralase® Technologies Inc.
View Trial →
NCT06370520 N/A
Recruiting
Screening Emotions in Adolescents at the Hospital for mTBI
Condition
Brain Injury Traumatic Mild
Enrollment
2,592 pts
Location
United States
Sponsor
University of California, Davi
View Trial →
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT06279637 N/A
Recruiting
Joint Patient and Caregiver Intervention for Older African Americans With Type 2...
Condition
Type 2 Diabetes
Enrollment
100 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT06392711 Phase 1
Recruiting
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xero...
Condition
Xerostomia
Enrollment
36 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Australia, Belgium
Sponsor
Kura Oncology, Inc.
View Trial →
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
View Trial →
NCT06581224 N/A
Recruiting
Implementation of a Primary Hospital Provider (PHP) Team
Condition
High-need, High-complexity
Enrollment
1,200 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06438315 N/A
Recruiting
SuperSaturated Oxygen Comprehensive Observational Registry
Condition
STEMI - ST Elevation Myocardial Infarction
Enrollment
1,000 pts
Location
United States
Sponsor
TherOx
View Trial →
NCT05377125 N/A
Recruiting
Neural Mechanisms of Response Inhibition Training for OCRD
Condition
Obsessive-Compulsive Disorder
Enrollment
118 pts
Location
United States
Sponsor
University of Wisconsin, Milwa
View Trial →
NCT05826535 Phase 1, Phase 2
Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Condition
Relapsed Non-Hodgkin Lymphoma
Enrollment
270 pts
Location
United States, Australia
Sponsor
Lyell Immunopharma, Inc.
View Trial →
Page 1 of 7 — 167 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology